Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
5.96
-0.04 (-0.67%)
At close: Oct 15, 2025, 4:00 PM EDT
5.97
+0.01 (0.17%)
After-hours: Oct 15, 2025, 7:58 PM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $1.28 billion as of October 15, 2025. Its market cap has increased by 556.29% in one year.
Market Cap
1.28B
Enterprise Value
1.19B
1-Year Change
556.29%
Ranking
Category
Stock Price
$5.96
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $1.28B, a decrease of -44.18%. That is a compound annual growth rate of -12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 1.28B | 472.40% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |